C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in cyprus: Clinical and molecular findings in 21 families

Advances in Experimental Medicine and Biology

Volumn 734, Issue , 2013, Pages 189-196

  Deltas, Constantinos ^a   Gale, Daniel ^b   Cook, Terence ^b   Voskarides, Konstantinos ^a   Athanasiou, Yiannis ^c   Pierides, Alkis ^d  

^a UNIVERSITY OF CYPRUS   (Cyprus)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NICOSIA GENERAL HOSPITAL   (Cyprus)

^d Hippocrateon Hospital   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H RELATED PROTEIN 5; UNCLASSIFIED DRUG;

ALPORT SYNDROME; AUTOSOMAL DOMINANT INHERITANCE; CFHR5 GENE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COLLAGEN 4 GENE; COMPLEMENT C3 GLOMERULONEPHRITIS; COMPLEMENT DEPOSITION; CONFERENCE PAPER; CYPRUS; DEMOGRAPHY; ENDEMIC DISEASE; FAMILY HISTORY; GENE; GENE CLUSTER; GENE DUPLICATION; GENE FUNCTION; GENE MUTATION; GENETIC VARIABILITY; GEOGRAPHY; GLOMERULONEPHRITIS; HEMATURIA; HETEROZYGOTE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOREGULATION; KIDNEY DISEASE; KIDNEY FAILURE; LINKAGE ANALYSIS; MOLECULAR DIAGNOSIS; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; THIN BASEMENT MEMBRANE NEPHROPATHY; ALGORITHM; C3 GLOMERULONEPHRITIS; CFHR5 NEPHROPATHY; CHRONIC KIDNEY FAILURE; COMORBIDITY; DISEASE EXACERBATION; DISEASE SEVERITY; END STAGE RENAL DISEASE; EXON; FAMILY STUDY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PEDIGREE ANALYSIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84934437759     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-4118-2_12     Document Type: Conference Paper

References (14)

1. Athanasiou Y, Voskarides K, Gale D, Damianou L, Patsias C, Zavros M et al (2011) Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees. Clin J Am Soc Nephrol 6:1436-14466
2. Deltas C (2004) Inherited diseases and Cyprus reality. A historico-genetic approach. In: The 30th annals of the Cyprus Research Center (Epetirida), Ministry of Education and Culture, Nicosia, Cyprus (Greek), pp 457-489
3. Deltas C, Pierides A, Voskarides K (2012) The role of molecular genetics in diagnosing familial hematuria(s). Pediatr Nephrol, DOI: 10.1007/s00467-011- 1935-55
4. Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, Adam G et al (2010) Identi fication of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 376:794-8011
5. Grekas D, Morley AR, Wilkinson R, Kerr DN (1984) Isolated C3 deposition in patients without systemic disease. Clin Nephrol 21:270-2744
6. Murphy B, Georgiou T, Machet D, Hill P, McRae J (2002) Factor H-related protein-5: a novel component of human glomerular immune deposits. Am J Kidney Dis 39:24-277
7. Kashtan CE (2005) Familial hematurias: what we know and what we don't. Pediatr Nephrol 20:1027-10355
8. Papagregoriou G, Erguler K, Dweep H, Voskarides K, Koupepidou P, Athanasiou A et al (2012) A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathy. PLoS ONE 7(2):e31021 [Epub 2012 Feb 2]
9. Pierides A, Voskarides K, Athanasiou Y, Ioannou K, Damianou L, Arsali M et al (2009) Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/COL4A44 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis. Nephrol Dial Transplant 24:2721-27299
10. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G (2002) Relative quanti fication of 40 nucleic acid sequences by multiplex ligation-dependent probe ampli fication. Nucleic Acids Res 30:e577
11. Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B et al (2007) Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet 44:193-1999
12. Voskarides K, Damianou L, Neocleous V, Zouvani I, Christodoulidou S, Hadjiconstantinou V et al (2007) COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy. J Am Soc Nephrol 18:3004-30166
13. Voskarides K , Patsias C, Pierides A, Deltas C (2008) COL4A3 Founder mutations in Greek-Cypriot families with thin basement membrane nephropathy and focal segmental glomerulosclerosis dating from around 18th century. Genet Test 12(2):273-2788
14. Voskarides K, Arsali M, Athanasiou Y, Elia A, Pierides A, Deltas C (2012) Evidence that NPHS2 -R229Q predisposes to proteinuria and renal failure in familial hematuria. Pediatr Nephrol, DOI: 10.1007/s00467-011-2084-66